Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
公司代码DMAAR
公司Drugs Made In America Acquisition Corp
CEOStockwell (Lynn)
网址
常见问题
Drugs Made In America Acquisition Corp(DMAAR)的当前股价是多少?
Drugs Made In America Acquisition Corp(DMAAR)的当前股价是 0.189。
Drugs Made In America Acquisition Corp的股票代码是什么?
Drugs Made In America Acquisition Corp的股票代码是DMAAR。
Drugs Made In America Acquisition Corp股票的52周最高点是多少?
Drugs Made In America Acquisition Corp股票的52周最高点是0.243。
Drugs Made In America Acquisition Corp股票的52周最低点是多少?
Drugs Made In America Acquisition Corp股票的52周最低点是0.090。
Drugs Made In America Acquisition Corp的市值是多少?
Drugs Made In America Acquisition Corp的市值是--。
Drugs Made In America Acquisition Corp的净利润是多少?
Drugs Made In America Acquisition Corp的净利润为--。
现在Drugs Made In America Acquisition Corp(DMAAR)的股票是买入、持有还是卖出?
根据分析师评级,Drugs Made In America Acquisition Corp(DMAAR)的总体评级为--,目标价格为--。
Drugs Made In America Acquisition Corp(DMAAR)股票的每股收益(EPS TTM)是多少
Drugs Made In America Acquisition Corp(DMAAR)股票的每股收益(EPS TTM)是--。